<span class="vcard">John Joseph</span>
John Joseph

The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage

Immunobiology. 2024 May 9;229(3):152808. doi: 10.1016/j.imbio.2024.152808. Online ahead of print. ABSTRACT OBJECTIVES: Although tumor necrosis factor-alpha inhibitor (TNFi) treatment may improve pregnancy outcomes in unexplained …

PYRIDOXINE-dependent epilepsy (PDE): An observational study of neonatal cases on the role of pyridoxine in patients treated with standard anti-seizure medications

Seizure. 2024 May 11;118:156-163. doi: 10.1016/j.seizure.2024.04.012. Online ahead of print. ABSTRACT BACKGROUND: The main objective of this study was to evaluate the neurological consequences of …

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial

World J Urol. 2024 May 13;42(1):316. doi: 10.1007/s00345-024-05025-x. NO ABSTRACT PMID:38736011 | DOI:10.1007/s00345-024-05025-x

Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA

Ann Hematol. 2024 May 13. doi: 10.1007/s00277-024-05780-2. Online ahead of print. ABSTRACT There has been no severity evaluation model for pediatric patients with hemophagocytic lymphohistiocytosis …